Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000183378 | SCV000235820 | benign | not specified | 2016-12-27 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000183378 | SCV000331601 | likely benign | not specified | 2015-11-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618151 | SCV000736505 | benign | Cardiovascular phenotype | 2018-10-23 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001084240 | SCV000751592 | benign | Duchenne muscular dystrophy | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000630627 | SCV001143753 | benign | not provided | 2018-12-03 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000630627 | SCV002047848 | likely benign | not provided | 2023-10-16 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000183378 | SCV002766250 | likely benign | not specified | 2022-11-13 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001833096 | SCV002087761 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2020-04-12 | no assertion criteria provided | clinical testing |